Will European Stem Cell Ruling Stifle Research?
My commentary on patenting stem cell techniques was published by LexisNexis and is available to view here.
Sector
Inventions
We provide advice on brand protection and comparative advertising issues, and split IP ownership and complex royalty arrangements. Working with a number of Trade Mark Attorneys, our team regularly advise on best practice for safeguarding inventions and registration issues and provide a full intellectual property service covering protection and exploitation of IP rights.
Key team contact
Paul Gershlick 01923 208816
paul.gershlick@mablaw.com
Latest news and views about Inventions
RSSProtect Your Position – Bristol-Myers buys Inhibitex for $2.5 billion
With the Patent Cliff looming and the lack of new drugs to fill the void keeping big Pharma bosses awake at night, we are seeing new strategies emerging in an attempt to off see the gloom and doom predictions...
AstraZeneca takes step forward to find partners to avoid effects of looming Patent Cliff
AstraZeneca, the UK's second biggest pharmaceutical company, has taken steps to counteract the severe consequences of the Patent Cliff. The Patent Cliff is the name given to the imminent loss of revenues...
Pharma industry sleepwalking into jump off patent cliff – survey
The pharmaceutical industry is sleepwalking to the edge of the patent cliff blindfolded. And there's going to be a huge drop this year with revenues falling by up to 40% as the big pharma companies will...
Government proposes change in law to make UK a better place to carry out drug research on patented products
The UK Government would like to change the law to make the UK a more amenable place to carry out clinical trials. There is an exemption from breach of patented pharmaceutical products when the use is in...
“The Patent Cliff – Lipitor goes over the Edge”
As the largest ever number of patents protecting the pharmaceutical industry’s most profitable “blockbuster” drugs are set to expire, for India and China it’s going to be a very merry Christmas...
OFT investigates pharma sector patent settlement agreements
The Office of Fair Trading has announced that it is investigating patent litigation agreements relating to paroxetine. Paroxetine is a medicine used in the treatment of disorders such as depression and...
Supreme Court awards patent for human protein and discovery of underlying gene sequence as it says English courts should follow European Patent Office Technical Board of Appeal where it has adopted a consistent approach – Human Genome Sciences v Eli Lilly, Supreme Court
HGS made a patent application for the human protein Neutrokine-alpha and the discovery of its underlying gene sequence. Eli Lilly challenged the patent application in the High Court and the European Patent...
Samsung seeks injunction to stop Apple iPhone 4S in four countries as Samsung is stopped from selling products for alleged infringement of Apple’s patents
Samsung’s and Apple’s patent tit-for-tat spat continues apace, with Samsung seeking injunctions in Australia, France, Italy and Japan to stop Apple’s sales of the iPhone 4S. Samsung has recently...
Intellectual Property Office relaxes exception to patentability for computerisation of mental act following recent High Court case
The Intellectual Property Office has relaxed the rules relating to the patentability of the computerisation of what would otherwise have been a mental act. This follows a High Court case which had ruled...
